Breast Cancer Res. 2000;2(3):184-90. Epub 2000 Mar 25.

Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification.

Prenzel N, Zwick E, Leserer M, Ullrich A.

Source

Max-Planck Institut für Biochemie, Department of Molecular Biology, Martinsried, Germany.

Abstract

Cross-communication between different signalling systems is critical for the integration of multiple and changing environmental influences on individual cells. The epidermal growth factor receptor (EGFR) has been identified as a key element in the complex signalling network that is utilized by various classes of cell-surface receptors. This nonclassical mode of signalling system cross-talk, in distinction to receptor activation induced by cognate ligands, has been termed 'signal transactivation'. With the EGFR as the convergence point and distribution focus, this scenario may involve signals emitted by other members of the tyrosine kinase family, cytokine receptors, ion channels, G-protein-coupled receptors and integrins.

PMID:: 11250708; [PubMed - indexed for MEDLINE]
PMCID: PMC138773

Free PMC Article

Images from this publication.See all images (2) Free text

Publication Types, MeSH Terms, Substances

LinkOut - more resources

Full Text Sources

Medical

Breast Cancer - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. [Breast Cancer Res. 2000]
Review Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer.
Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ. Breast Cancer Res. 2000; 2(3):203-10. Epub 2000 Mar 7.
Review Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases. [Breast Cancer Res. 2000]
Review Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases.
Stern DF. Breast Cancer Res. 2000; 2(3):176-83. Epub 2000 Mar 25.
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. [Breast Cancer Res. 2007]
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE. Breast Cancer Res. 2007; 9(5):R63.
Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. [Cancer Res. 2007]
Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
Lahusen T, Fereshteh M, Oh A, Wellstein A, Riegel AT. Cancer Res. 2007 Aug 1; 67(15):7256-65.
Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. [J Biol Chem. 2001]
Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade.
Andreev J, Galisteo ML, Kranenburg O, Logan SK, Chiu ES, Okigaki M, Cary LA, Moolenaar WH, Schlessinger J. J Biol Chem. 2001 Jun 8; 276(23):20130-5. Epub 2001 Mar 27.

See reviews... See all...

Cited by 14 PubMed Central articles

Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy. [PLoS One. 2011]
Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.
Du WW, Yang BB, Yang BL, Deng Z, Fang L, Shan SW, Jeyapalan Z, Zhang Y, Seth A, Yee AJ. PLoS One. 2011; 6(11):e26396. Epub 2011 Nov 9.
Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells. [Neoplasia. 2011]
Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells.
Haim K, Weitzenfeld P, Meshel T, Ben-Baruch A. Neoplasia. 2011 Mar; 13(3):230-43.
An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. [Mol Cell Proteomics. 2011]
An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.
Han CL, Chen JS, Chan EC, Wu CP, Yu KH, Chen KT, Tsou CC, Tsai CF, Chien CW, Kuo YB, et al. Mol Cell Proteomics. 2011 Apr; 10(4):M110.003087. Epub 2011 Jan 5.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: c...
Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification.
Breast Cancer Res. 2000 ;2(3):184-90. Epub 2000 Mar 25 .

PubMed
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer ris...
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.
Endocr Relat Cancer. 2006 Jun ;13(2):273-8.

PubMed
Occult central nervous system involvement in patients with metastatic breast can...
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.
Ann Oncol. 2003 Jul ;14(7):1072-7.

PubMed
Metastatic breast cancer: clinical course, prognosis and therapy related to the ...
Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis.
Breast Cancer Res Treat. 2000 Feb ;59(3):271-8.

PubMed
Is breast cancer prognosis inherited?
Is breast cancer prognosis inherited?
Breast Cancer Res. 2007 ;9(3):R39.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Libraries

Supplemental Content

Related citations

Cited by 14 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information